FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate

BACKGROUND: Patients with bipolar disorder are at high risk of metabolic disturbance after mood stabilizer treatment. However, the mediators linking the two conditions remain unknown. In this study, we investigated whether fibroblast growth factor-21 (FGF21) was associated with metabolic effects and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Neuropsychopharmacol
Huvudupphovsmän: Chang, Hui Hua, Chen, Po See, Cheng, Yung Wen, Wang, Tzu-Yun, Yang, Yen Kuang, Lu, Ru-Band
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Regular Research Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888470/
https://ncbi.nlm.nih.gov/pubmed/29618013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx093
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk